_id
6915ec05bc934aba376b1d30
Ticker
RAJAF
Name
RAJAF
Exchange
OTCQB
Address
No. 15, Lane 548, Taipei, Taiwan
Country
USA
Sector
Consumer Defensive
Industry
Packaged Foods
Currency
USD
Website
-
Description
Cordyceps Sunshine Biotech Holdings Co., Ltd. engages in the cultivation and sale of Chinese rare medicinal herb, taiwanofungus raw material, and finished products in China. The company offers Taiwanofungus Oral pill, a pill form dietary supplement; Taiwanofungus Double A Oral shot, TAIWANOFUNGUS x SALVIA MILTIORRHIZA ORAL Shot, and Collagen Max Drink, a liquid form dietary supplement; and Barbie Coco, a chocolate product. It also exports its products to Hong Kong and Mainland China. The company offers its products through online e-commerce platforms, physical chain stores, collaboration with major retail brands, and partnerships with retail channels. Cordyceps Sunshine Biotech Holdings Co., Ltd. was incorporated in 2020 and is based in Taipei, Taiwan.
Last Close
9.18
Volume
-
Current Price
9.18
Change
0
Last Updated
2026-01-06T09:58:49.028Z
Image
-
Ipo Date
-
Market Cap
1020081664
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-12-31
Revenue
315502
Cost Of Revenue
30842
Gross Profit
284660
Operating Expenses
197503
Operating Income
117999
Interest Expense
-
Pretax Income
91930
Net Income
973422
Eps
0.008760097192224621
Dividends Per Share
-
Shares Outstanding
111120000
Income Tax Expense
-
EBITDA
-
Operating Margin
37.40039682791234
Total Other Income Expense Net
-
Cash
23104
Short Term Investments
-
Receivables
0
Inventories
195359
Total Current Assets
327175
Property Plant Equipment
3010541
Total Assets
3351782
Payables
185434
Short Term Debt
-
Long Term Debt
431079
Total Liabilities
3503578
Equity
-151796
Bs_currency_symbol
USD
Depreciation
174041
Change In Working Capital
-1604456
Cash From Operations
-1267759
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
19171
Net Change In Cash
-3192
Cf_currency_symbol
USD
PE
0
PB
-6720.0822156051545
ROE
-641.2698621834568
ROA
29.041924564306388
FCF
-1267759
Fcf Percent
-4.018228093641245
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
3.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
6
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
1
Net Net Investing Score
0.5
Quality Investing Score
3
Value Investing Score
4.5
Quarters > 0 > quarter
2023-12-31
Quarters > 0 > income Statement > revenue
315502
Quarters > 0 > income Statement > cost Of Revenue
30842
Quarters > 0 > income Statement > gross Profit
284660
Quarters > 0 > income Statement > operating Expenses
197503
Quarters > 0 > income Statement > operating Income
117999
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
91930
Quarters > 0 > income Statement > net Income
973422
Quarters > 0 > income Statement > eps
0.008760097192224621
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
111120000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
37.40039682791234
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
23104
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
0
Quarters > 0 > balance Sheet > inventories
195359
Quarters > 0 > balance Sheet > total Current Assets
327175
Quarters > 0 > balance Sheet > property Plant Equipment
3010541
Quarters > 0 > balance Sheet > total Assets
3351782
Quarters > 0 > balance Sheet > payables
185434
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
431079
Quarters > 0 > balance Sheet > total Liabilities
3503578
Quarters > 0 > balance Sheet > equity
-151796
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
973422
Quarters > 0 > cash Flow > depreciation
174041
Quarters > 0 > cash Flow > change In Working Capital
-1604456
Quarters > 0 > cash Flow > cash From Operations
-1267759
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
19171
Quarters > 0 > cash Flow > net Change In Cash
-3192
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
0.008760097192224621
Quarters > 0 > ratios > PB
-6720.0822156051545
Quarters > 0 > ratios > ROE
-641.2698621834568
Quarters > 0 > ratios > ROA
29.041924564306388
Quarters > 0 > ratios > FCF
-1267759
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-4.018228093641245
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2022-12-31
Quarters > 1 > income Statement > revenue
448785
Quarters > 1 > income Statement > cost Of Revenue
515457
Quarters > 1 > income Statement > gross Profit
-66672
Quarters > 1 > income Statement > operating Expenses
713267
Quarters > 1 > income Statement > operating Income
-264482
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-341081
Quarters > 1 > income Statement > net Income
-77046
Quarters > 1 > income Statement > eps
-0.0006933585313174946
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
111120000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-58.932896598593985
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
6628
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
149510
Quarters > 1 > balance Sheet > inventories
0
Quarters > 1 > balance Sheet > total Current Assets
501552
Quarters > 1 > balance Sheet > property Plant Equipment
253676
Quarters > 1 > balance Sheet > total Assets
2104853
Quarters > 1 > balance Sheet > payables
0
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
414000
Quarters > 1 > balance Sheet > total Liabilities
3056187
Quarters > 1 > balance Sheet > equity
-951334
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-157263
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-110817
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-34538
Quarters > 1 > cash Flow > net Change In Cash
-1756
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.0006933585313174946
Quarters > 1 > ratios > PB
-1072.2644202772105
Quarters > 1 > ratios > ROE
8.098732937117774
Quarters > 1 > ratios > ROA
-3.6603981370670544
Quarters > 1 > ratios > FCF
-110817
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-0.24692670209565828
Quarters > 1 > health Score
21
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1253484
Annuals > 0 > income Statement > cost Of Revenue
719724
Annuals > 0 > income Statement > gross Profit
533760
Annuals > 0 > income Statement > operating Expenses
1437397
Annuals > 0 > income Statement > operating Income
-183913
Annuals > 0 > income Statement > interest Expense
17055
Annuals > 0 > income Statement > pretax Income
-191301
Annuals > 0 > income Statement > net Income
-226258
Annuals > 0 > income Statement > eps
-0.0020361591072714184
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
111120000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-14.672145795239508
Annuals > 0 > income Statement > total Other Income Expense Net
9667
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
37284
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
305
Annuals > 0 > balance Sheet > inventories
304971
Annuals > 0 > balance Sheet > total Current Assets
601602
Annuals > 0 > balance Sheet > property Plant Equipment
4008927
Annuals > 0 > balance Sheet > total Assets
4623704
Annuals > 0 > balance Sheet > payables
276125
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
4999247
Annuals > 0 > balance Sheet > equity
-375543
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-226258
Annuals > 0 > cash Flow > depreciation
424058
Annuals > 0 > cash Flow > change In Working Capital
101802
Annuals > 0 > cash Flow > cash From Operations
312006
Annuals > 0 > cash Flow > capital Expenditures
349237
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
0
Annuals > 0 > cash Flow > net Change In Cash
14180
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.0020361591072714184
Annuals > 0 > ratios > PB
-2716.284420159609
Annuals > 0 > ratios > ROE
60.24822723363237
Annuals > 0 > ratios > ROA
-4.893436085008902
Annuals > 0 > ratios > FCF
-37231
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-0.02970201454506001
Annuals > 0 > health Score
32
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
882533
Annuals > 1 > income Statement > cost Of Revenue
116146
Annuals > 1 > income Statement > gross Profit
766387
Annuals > 1 > income Statement > operating Expenses
654700
Annuals > 1 > income Statement > operating Income
227833
Annuals > 1 > income Statement > interest Expense
39770
Annuals > 1 > income Statement > pretax Income
190815
Annuals > 1 > income Statement > net Income
751609
Annuals > 1 > income Statement > eps
0.0067639398848092155
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
111120000
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
25.815805188021297
Annuals > 1 > income Statement > total Other Income Expense Net
2752
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
23104
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
0
Annuals > 1 > balance Sheet > inventories
195359
Annuals > 1 > balance Sheet > total Current Assets
327175
Annuals > 1 > balance Sheet > property Plant Equipment
3010541
Annuals > 1 > balance Sheet > total Assets
3351782
Annuals > 1 > balance Sheet > payables
185434
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
431079
Annuals > 1 > balance Sheet > total Liabilities
3503578
Annuals > 1 > balance Sheet > equity
-151796
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
751609
Annuals > 1 > cash Flow > depreciation
56757
Annuals > 1 > cash Flow > change In Working Capital
61887
Annuals > 1 > cash Flow > cash From Operations
359724
Annuals > 1 > cash Flow > capital Expenditures
319487
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
14643
Annuals > 1 > cash Flow > net Change In Cash
7004
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
0.0067639398848092155
Annuals > 1 > ratios > PB
-6720.0822156051545
Annuals > 1 > ratios > ROE
-495.144140820575
Annuals > 1 > ratios > ROA
22.424161237216502
Annuals > 1 > ratios > FCF
40237
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
0.045592629397427635
Annuals > 1 > health Score
43
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
53304
Annuals > 2 > income Statement > cost Of Revenue
13746
Annuals > 2 > income Statement > gross Profit
39558
Annuals > 2 > income Statement > operating Expenses
468425
Annuals > 2 > income Statement > operating Income
-415121
Annuals > 2 > income Statement > interest Expense
71772
Annuals > 2 > income Statement > pretax Income
-415111
Annuals > 2 > income Statement > net Income
-720093
Annuals > 2 > income Statement > eps
-0.006480318574514039
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
111120000
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-778.7802041122618
Annuals > 2 > income Statement > total Other Income Expense Net
-4855
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
6628
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
149510
Annuals > 2 > balance Sheet > inventories
0
Annuals > 2 > balance Sheet > total Current Assets
501552
Annuals > 2 > balance Sheet > property Plant Equipment
253676
Annuals > 2 > balance Sheet > total Assets
2104853
Annuals > 2 > balance Sheet > payables
0
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
414000
Annuals > 2 > balance Sheet > total Liabilities
3056187
Annuals > 2 > balance Sheet > equity
-951334
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-720093
Annuals > 2 > cash Flow > depreciation
81156
Annuals > 2 > cash Flow > change In Working Capital
-60896
Annuals > 2 > cash Flow > cash From Operations
-321378
Annuals > 2 > cash Flow > capital Expenditures
475
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
309263
Annuals > 2 > cash Flow > net Change In Cash
-83584
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.006480318574514039
Annuals > 2 > ratios > PB
-1072.2644202772105
Annuals > 2 > ratios > ROE
75.6929742866333
Annuals > 2 > ratios > ROA
-34.211082674181995
Annuals > 2 > ratios > FCF
-321853
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-6.038064685577067
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
0
Annuals > 3 > income Statement > gross Profit
0
Annuals > 3 > income Statement > operating Expenses
119387
Annuals > 3 > income Statement > operating Income
-119387
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-119380
Annuals > 3 > income Statement > net Income
-491006
Annuals > 3 > income Statement > eps
-0.004418700503959683
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
111120000
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-1138
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
99684
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
358006
Annuals > 3 > balance Sheet > inventories
480352
Annuals > 3 > balance Sheet > total Current Assets
1130828
Annuals > 3 > balance Sheet > property Plant Equipment
1986170
Annuals > 3 > balance Sheet > total Assets
3263038
Annuals > 3 > balance Sheet > payables
1227598
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
414000
Annuals > 3 > balance Sheet > total Liabilities
3538851
Annuals > 3 > balance Sheet > equity
-275813
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-491006
Annuals > 3 > cash Flow > depreciation
4932
Annuals > 3 > cash Flow > change In Working Capital
-26199
Annuals > 3 > cash Flow > cash From Operations
-365363
Annuals > 3 > cash Flow > capital Expenditures
100000
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
328258
Annuals > 3 > cash Flow > net Change In Cash
99390
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.004418700503959683
Annuals > 3 > ratios > PB
-3698.453662445207
Annuals > 3 > ratios > ROE
178.0213405459496
Annuals > 3 > ratios > ROA
-15.047510939192248
Annuals > 3 > ratios > FCF
-465363
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
0.008760097192224621
Valuation > metrics > PB
-6720.0822156051545
Valuation > final Score
70
Valuation > verdict
99.9% Undervalued
Profitability > metrics > ROE
-641.2698621834568
Profitability > metrics > ROA
297.52334377626653
Profitability > metrics > Net Margin
3.085311662049686
Profitability > final Score
60
Profitability > verdict
Adequate
Risk > final Score
50
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.764374386574199
Liquidity > metrics > Quick Ratio
0.7108513001930606
Liquidity > final Score
80
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
0
Prev Valuations > 2
0
Prev Profitabilities > 0
16
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
50
Prev Risks > 1
0
Prev Risks > 2
0
Prev Liquidities > 0
50
Prev Liquidities > 1
0
Prev Liquidities > 2
0
Updated At
2026-01-20T22:27:36.680Z
Earnings History > 0 > period
2023-12-31
Earnings History > 0 > report Date
2023-12-31
Earnings History > 0 > date
2023-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
0.0088
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Cordyceps Sunshine Biotech Holdings Co., Ltd. engages in the cultivation and sale of Chinese rare medicinal herb, taiwanofungus raw material, and finished products in China. The company offers Taiwanofungus Oral pill, a pill form dietary supplement; Taiwanofungus Double A Oral shot, TAIWANOFUNGUS x SALVIA MILTIORRHIZA ORAL Shot, and Collagen Max Drink, a liquid form dietary supplement; and Barbie Coco, a chocolate product. It also exports its products to Hong Kong and Mainland China. The company offers its products through online e-commerce platforms, physical chain stores, collaboration with major retail brands, and partnerships with retail channels. Cordyceps Sunshine Biotech Holdings Co., Ltd. was incorporated in 2020 and is based in Taipei, Taiwan.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2023-12-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very High
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of RAJAF
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2023-12-31
EPS Actual
0.0088
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2023-12-31)
(Last Updated 2023-12-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-12-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-12-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.